Atlas Trials

Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer

Clinical trial NCT07673016 · RECRUITING

Trial details

NCT number
NCT07673016
Sponsor
Convergent Genomics, Inc.
Status
RECRUITING
Study type
OBSERVATIONAL
Bladder CancerUrothelial Carcinoma (UC)HematuriaUpper Tract Urothelial Cancer
Start date
2019-10-15
Primary completion
2034-12-01
Enrollment
2500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.